438
50. Reung-U-Rai A, Prom-Jun A, Prissanaroon-Ouajai W, Ouajai S. Synthesis of highly conductive polypyrrole nanoparticles via microemulsion polymerization. J Metals Mater Miner.
2008;18(2):27–31.
51. Weiss CK, Ziener U, Landfester K. A route to nonfunctionalized and functionalized poly
(n-butylcyanoacrylate) nanoparticles: preparation in miniemulsion. Macromolecules. 2007;
40(4):928–38.
52. Kim M-S, Baek I-H. Fabrication and evaluation of valsartan–polymer–surfactant composite nanoparticles by using the supercritical antisolvent process. Int. J. Nanomedicine.
2014;9:5167.
53. Reverchon E, Adami R, Caputo G, De Marco I. Spherical microparticles production by
supercritical antisolvent precipitation: interpretation of results. J Supercrit Fluids. 2008;
47(1):70–84.
54. Pasquali I, Bettini R. Are pharmaceutics really going supercritical? Int J Pharm. 2008;
364(2):176–87.
55. Meziani MJ, Pathak P, Sun Y-P. Supercritical fluid technology for nanotechnology in drug
delivery. Nanotechnol Drug Deliv. 2009:69–104.
56. Spasic AM, Hsu J-P. Finely Dispersed Particles: Micro-, Nano-, and Atto-Engineering. Boca
Raton: CRC Press; 2005.
57. Girotra P, Singh SK, Nagpal K. Supercritical fluid technology: a promising approach in pharmaceutical research. Pharm. Dev. Technol. 2013;18(1):22–38.
58. Yoshida V, Hanai IM, Balcão V, Vila MMDC, Júnior JMO, Aranha N, et al. Supercritical
fluid and pharmaceutical applications. Part I: process classification. Afr J Pharm Pharmacol.
2016;10(9):132–44.
59. Kalani M, Yunus R. Application of supercritical antisolvent method in drug encapsulation: a
review. Int J Nanomedicine. 2011;6(142):9–42.
60. Rantakylä M, Jäntti M, Aaltonen O, Hurme M. The effect of initial drop size on particle
size in the supercritical antisolvent precipitation (SAS) technique. J Supercrit Fluids.
2002;24(3):251–63.
61. Chen A-Z, Li Y, Chau F-T, Lau T-Y, Hu J-Y, Zhao Z, et al. Application of organic nonsolvent
in the process of solution-enhanced dispersion by supercritical CO 2 to prepare puerarin fine
particles. J Supercrit Fluids. 2009;49(3):394–402.
62. Byrappa K, Ohara S, Adschiri T. Nanoparticles synthesis using supercritical fluid technology–towards biomedical applications. Adv Drug Deliv Rev. 2008;60(3):299–327.
63. Miguel F, Martin A, Gamse T, Cocero M. Supercritical anti solvent precipitation of lycopene:
effect of the operating parameters. J Supercrit Fluids. 2006;36(3):225–35.
64. Majerik V, Charbit G, Badens E, Horváth G, Szokonya L, Bosc N, et al. Bioavailability
enhancement of an active substance by supercritical antisolvent precipitation. J Supercrit
Fluids. 2007;40(1):101–10.
65. Sacha GA, Schmitt WJ, Nail SL. Identification of physical-chemical variables affecting particle size following precipitation using a supercritical fluid. Pharm Dev Technol.
2006;11(2):195–205.
66. Sane A, Thies MC. Effect of material properties and processing conditions on RESS of poly
(l-lactide). J Supercrit Fluids. 2007;40(1):134–43.
67. Kostag M, Köhler S, Liebert T, Heinze T. Pure cellulose nanoparticles from trimethylsilyl
cellulose. In: Macromolecular Symposia. Hoboken: Wiley; 2010.
68. Betancourt T, Brown B, Brannon-Peppas L. Doxorubicin-loaded PLGA nanoparticles by
nanoprecipitation: preparation, characterization and in vitro evaluation. Nanomedicne
(Lond). 2007;2(2):219–32.
69. Bisht S, Feldmann G, Soni S, Ravi R, Karikar C, Maitra A, et al. Polymeric nanoparticleencapsulated curcumin (" nanocurcumin"): a novel strategy for human cancer therapy. J
Nanobiotechnol. 2007;5(1):1.
Z. Iqbal et al.
50. Reung-U-Rai A, Prom-Jun A, Prissanaroon-Ouajai W, Ouajai S. Synthesis of highly conductive polypyrrole nanoparticles via microemulsion polymerization. J Metals Mater Miner.
2008;18(2):27–31.
51. Weiss CK, Ziener U, Landfester K. A route to nonfunctionalized and functionalized poly
(n-butylcyanoacrylate) nanoparticles: preparation in miniemulsion. Macromolecules. 2007;
40(4):928–38.
52. Kim M-S, Baek I-H. Fabrication and evaluation of valsartan–polymer–surfactant composite nanoparticles by using the supercritical antisolvent process. Int. J. Nanomedicine.
2014;9:5167.
53. Reverchon E, Adami R, Caputo G, De Marco I. Spherical microparticles production by
supercritical antisolvent precipitation: interpretation of results. J Supercrit Fluids. 2008;
47(1):70–84.
54. Pasquali I, Bettini R. Are pharmaceutics really going supercritical? Int J Pharm. 2008;
364(2):176–87.
55. Meziani MJ, Pathak P, Sun Y-P. Supercritical fluid technology for nanotechnology in drug
delivery. Nanotechnol Drug Deliv. 2009:69–104.
56. Spasic AM, Hsu J-P. Finely Dispersed Particles: Micro-, Nano-, and Atto-Engineering. Boca
Raton: CRC Press; 2005.
57. Girotra P, Singh SK, Nagpal K. Supercritical fluid technology: a promising approach in pharmaceutical research. Pharm. Dev. Technol. 2013;18(1):22–38.
58. Yoshida V, Hanai IM, Balcão V, Vila MMDC, Júnior JMO, Aranha N, et al. Supercritical
fluid and pharmaceutical applications. Part I: process classification. Afr J Pharm Pharmacol.
2016;10(9):132–44.
59. Kalani M, Yunus R. Application of supercritical antisolvent method in drug encapsulation: a
review. Int J Nanomedicine. 2011;6(142):9–42.
60. Rantakylä M, Jäntti M, Aaltonen O, Hurme M. The effect of initial drop size on particle
size in the supercritical antisolvent precipitation (SAS) technique. J Supercrit Fluids.
2002;24(3):251–63.
61. Chen A-Z, Li Y, Chau F-T, Lau T-Y, Hu J-Y, Zhao Z, et al. Application of organic nonsolvent
in the process of solution-enhanced dispersion by supercritical CO 2 to prepare puerarin fine
particles. J Supercrit Fluids. 2009;49(3):394–402.
62. Byrappa K, Ohara S, Adschiri T. Nanoparticles synthesis using supercritical fluid technology–towards biomedical applications. Adv Drug Deliv Rev. 2008;60(3):299–327.
63. Miguel F, Martin A, Gamse T, Cocero M. Supercritical anti solvent precipitation of lycopene:
effect of the operating parameters. J Supercrit Fluids. 2006;36(3):225–35.
64. Majerik V, Charbit G, Badens E, Horváth G, Szokonya L, Bosc N, et al. Bioavailability
enhancement of an active substance by supercritical antisolvent precipitation. J Supercrit
Fluids. 2007;40(1):101–10.
65. Sacha GA, Schmitt WJ, Nail SL. Identification of physical-chemical variables affecting particle size following precipitation using a supercritical fluid. Pharm Dev Technol.
2006;11(2):195–205.
66. Sane A, Thies MC. Effect of material properties and processing conditions on RESS of poly
(l-lactide). J Supercrit Fluids. 2007;40(1):134–43.
67. Kostag M, Köhler S, Liebert T, Heinze T. Pure cellulose nanoparticles from trimethylsilyl
cellulose. In: Macromolecular Symposia. Hoboken: Wiley; 2010.
68. Betancourt T, Brown B, Brannon-Peppas L. Doxorubicin-loaded PLGA nanoparticles by
nanoprecipitation: preparation, characterization and in vitro evaluation. Nanomedicne
(Lond). 2007;2(2):219–32.
69. Bisht S, Feldmann G, Soni S, Ravi R, Karikar C, Maitra A, et al. Polymeric nanoparticleencapsulated curcumin (" nanocurcumin"): a novel strategy for human cancer therapy. J
Nanobiotechnol. 2007;5(1):1.
Z. Iqbal et al.